GNH USA

Europe — EMA

Paliperidone Liconsa (Paliperidone Palmitate)

GNH USA supplies Paliperidone Liconsa (Paliperidone Palmitate), an atypical antipsychotic for schizophrenia and schizoaffective disorder.

Paliperidone Palmitate

Request sourcing

1
Pack/s

What is Paliperidone Palmitate?

Paliperidone Palmitate, the active ingredient in Paliperidone Liconsa, is an atypical antipsychotic presented as a long‑acting intramuscular injection for use in adults diagnosed with schizophrenia or schizoaffective disorder. It provides sustained dopamine D2 and serotonin 5‑HT2A receptor antagonism, allowing monthly dosing to support symptom control and relapse prevention.

GNH USA supplies Paliperidone Liconsa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured product handling, regulatory compliance and reliable global logistics for mental health treatment programs.

What is Paliperidone Palmitate used for?

Paliperidone Liconsa, an atypical antipsychotic, is indicated for the treatment of psychotic disorders that involve dopamine dysregulation.

- Schizophrenia: reduces acute psychotic symptoms and helps prevent relapse. - Schizoaffective disorder: stabilises both mood and psychotic features. - Maintenance therapy for schizophrenia: provides once‑monthly dosing to sustain symptom control.

What are the side effects of Paliperidone Palmitate?

Common Side Effects: - Injection site pain or irritation. - Weight gain. - Akathisia or restlessness. - Somnolence or fatigue. - Headache. - Constipation.

Serious or Rare Side Effects: - Tardive dyskinesia. - Neuroleptic malignant syndrome. - Severe hypotension. - Hyperglycaemia or new‑onset diabetes. - Seizures. - Elevated prolactin leading to galactorrhoea or menstrual disturbances.

What precautions apply to Paliperidone Palmitate?

Before initiating therapy, clinicians should consider several safety measures.

- Monitor metabolic parameters: regularly assess weight, fasting glucose and lipid profile. - Assess for extrapyramidal symptoms: watch for tremor, rigidity or abnormal movements. - Screen cardiovascular status: evaluate blood pressure and obtain ECG if indicated. - Avoid abrupt discontinuation: taper under medical supervision to reduce withdrawal risk. - Pregnancy and lactation: use only if potential benefit justifies potential risk to fetus or infant. - Store at ambient temperature: keep in original container, protect from moisture and light.

What does Paliperidone Palmitate interact with?

Paliperidone Liconsa may interact with several drug classes.

Major Interactions (Avoid): - Strong CYP2D6 inhibitors: may increase paliperidone plasma concentrations. - Other dopamine antagonists: heightened risk of extrapyramidal symptoms. - QT‑prolonging agents: potential additive cardiac risk.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance hypotensive effect. - CNS depressants (e.g., benzodiazepines): additive sedation. - Carbamazepine or other enzyme inducers: may reduce paliperidone efficacy.

Frequently asked questions

What is Paliperidone Liconsa used for?+
Paliperidone Liconsa is a long‑acting intramuscular formulation of paliperidone palmitate indicated for the treatment of schizophrenia and schizoaffective disorder in adults. It is used to control acute psychotic episodes and to maintain symptom stability over a monthly dosing interval.
How does Paliperidone Palmitate work?+
Paliperidone Palmitate works by blocking dopamine D2 receptors and serotonin 5‑HT2A receptors, while also modulating other serotonergic and adrenergic pathways. This combined antagonism reduces dopaminergic over‑activity that underlies psychotic symptoms and helps stabilise mood.
What is the usual dose of Paliperidone Liconsa?+
The dosing regimen for Paliperidone Liconsa is determined by the prescribing clinician based on the patient’s clinical status, prior response to oral paliperidone, and any loading‑dose requirements. The prescriber will decide the exact dose and injection schedule.
Is Paliperidone Liconsa safe in pregnancy or breastfeeding?+
Limited clinical data are available for Paliperidone Liconsa during pregnancy and lactation. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.
How do I order Paliperidone Liconsa from GNH USA?+
To order Paliperidone Liconsa, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.
How does Paliperidone Liconsa compare with other antipsychotics?+
Paliperidone Liconsa offers a once‑monthly injectable option, which can improve adherence compared with daily oral antipsychotics. Compared with other long‑acting injectables such as risperidone microspheres, it provides a different dosing schedule and may have a distinct side‑effect profile, particularly regarding prolactin elevation and metabolic changes.
How should Paliperidone Liconsa be stored and handled?+
Paliperidone Liconsa should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperatures. Do not freeze the vials, and keep them out of reach of children.
How is Paliperidone Liconsa administered?+
Paliperidone Liconsa is administered by a qualified healthcare professional as an intramuscular injection, typically into the gluteal or deltoid muscle. The injection is given once every four weeks after any required loading doses, and the site should be rotated according to clinical guidelines.
What are the most serious risks to watch for with Paliperidone Liconsa?+
Serious risks include tardive dyskinesia, neuroleptic malignant syndrome, severe hypotension, hyperglycaemia, and seizures. Patients should be monitored for early signs of these conditions, and any concerning symptoms should prompt immediate medical evaluation.
Who should not use Paliperidone Liconsa?+
Paliperidone Liconsa is contraindicated in individuals with known hypersensitivity to paliperidone or any excipients in the formulation. Caution is advised for patients with uncontrolled cardiovascular disease, severe hepatic impairment, or a history of neuroleptic malignant syndrome.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Paliperidone Palmitate
Route
Intramuscular Use
Manufacturer
Laboratorios Liconsa, S.A.
Origin
EU

Related products

Arion

Arion

Paliperidone Palmitate

Belupo D.D.
EU
Baceq

Baceq

Paliperidone Palmitate

Abz-Pharma Gmbh
EU
Baceq

Baceq

Paliperidone Palmitate

Teva Pharma S.L.U.,
EU
Byannli

Byannli

Paliperidone Palmitate

Janssen-Cilag International Nv
EU